Access individual 2019 reporting measures for MIPS by clicking the links in the table below. You can also access information on 2020 reporting measures.
Melanoma: Coordination of Care
Percentage of patients with a new occurrence of melanoma who have their melanoma treatment plan sent to the physician providing continuity of care.
Melanoma: Continuity of Care – Recall System
Percentage of patients with melanoma who have their information entered into a recall system.
Percentage of patients who have biopsy results sent to another physician.
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis on a Biological Immune Response Modifier
Percentage of patients who are screened for TB when they have psoriasis, psoriatic arthritis, or rheumatoid arthritis and are also on a biological immune response modifier.
Psoriasis: Clinical Response to Systemic Medications
Percentage of patients receiving systematic medication who meet minimal physician or patient-reported disease activity levels.
Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time – Pathologist to Clinician
Percentage of biopsies in which the results are sent back to the clinician within seven days.
Medication Reconciliation Post-Discharge
Percentage of patients who are discharged from an inpatient facility and have their discharge medication list reconciled with the current medication list.
Advance Care Plan
Percentage of patients aged 65 or older who have been counseled on creating an advance care plan.
Preventive Care and Screening: Influenza Immunization
Percentage of patients who have received an influenza vaccine during flu season.
Pneumococcal Vaccination Status for Older Adults
Percentage of patients aged 65 or older who receive pneumococcal vaccination.
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
Percentage of patients aged 18 or older who have BMI measured, and when BMI is outside of normal parameters, receive a follow-up plan.
Documentation of Current Medications in the Medical Record
Percentage of patients who have a comprehensive current medication list.
Pain Assessment and Follow-Up
Percentage of patients who have their pain evaluated, and when pain is present, receive a follow-up plan.
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
Percentage of adult patients screened for unhealthy alcohol use, and when unhealthy use is present, receive brief counseling.
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
Percentage of patients who are screened for high blood pressure, and when high blood pressure is present, receive a follow-up plan.
HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis
Percentage of patients aged 13 years or older with a diagnosis of HIV/AIDS who are screened for chlamydia, gonorrhea, and syphilis.
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of adult patients who are screened for tobacco use, and if identified as a tobacco user, receive tobacco cessation intervention.
Patient-Centered Surgical Risk Assessment and Communication
Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery and who discussed those risks with the surgeon.
Percentage of pathology reports for primary malignant cutaneous melanoma that include the pT category and a statement on thickness, ulceration, and mitotic rate.
Tobacco Use and Help with Quitting Among Adolescents
Percentage of adolescents that are screened for tobacco use, and if identified as a tobacco user, receive tobacco cessation intervention.
Closing the Referral Loop: Receipt of Specialist Report
Percentage of patients who are referred and the referring provider receives a report from the other provider.
Access individual reporting measures for QCDR by clicking the links in the table below.
|Measure||Measure name||Measure description|
|Psoriasis: Screening for Psoriatic Arthritis|
Percentage of patients with a diagnosis of psoriasis who are screened for psoriatic arthritis.
|AAD 5||Biopsy: Reporting Time - Clinician to Patient|
Percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal or squamous cell carcinoma (including in situ disease) who are notified of their final biopsy pathology findings within 14 days.
|ACMS 1 |
|Adherence to Mohs Micrographic Surgery Appropriate Use Criteria|
Percentage of Mohs micrographic surgery cases that meet criteria according to published Mohs surgery appropriate use criteria (AUC) guidelines.
This table shows measures that are topped out.
|Topped out for MIPS reporting||Topped out for registry reporting|
|Measure 265||Measure 130|
|Measure 440||Measure AAD2|
|Measure 46||Measure AAD5|
|Measure 128 (for claims)|
|Measure 130 (for claims)|
|Measure 131 (for claims)|